Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9MA1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,862
Award facts
- Contract value 100% obligated
- $29,861.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,861.60 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of IMFINZI 500 mg/10 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of February 10, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, operating under its parent entity Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio encompasses a wide range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a single-award prime contractor on the DLA Troop Support Medical IDC, Cencora demonstrates significant capability in fulfilling government requirements for essential pharmaceutical and medical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9MA1?
SPE2DR26F9MA1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9MA1 worth?
The government has obligated $29,862 on SPE2DR26F9MA1.
Is contract SPE2DR26F9MA1 an order under another contract?
Yes. SPE2DR26F9MA1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MA1 competed?
The extent of competition for SPE2DR26F9MA1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award